N-able Expects Q4 Revenue of $133M-$134M
N-able expects fourth-quarter revenue of $133.0 million to $134.0 million.
Related stories
Dyne Therapeutics Reports $193.6 Million Q3 Net Loss
Dyne reported a Q3 2026 net loss of $193.6 million, or $1.06 per share, versus a $108.0 million loss, or $0.76 per share, in Q3 2025. Cash and marketable securities totaled $1.134
M impact | EQUITY | Nov 05, 2026, 12:45 PM UTC
Enovix cuts about 220 employee and contract-labor positions
The reduction represents about 220 of 946 positions and is expected to save $8.5 million per year.
M impact | EQUITY | Nov 05, 2026, 12:44 PM UTC
Cabaletta Bio reports a $53.1 million third-quarter loss
M impact | EQUITY | Nov 05, 2026, 12:33 PM UTC
McGraw Hill Q2 Revenue Falls 5.5% as K-12 Declines
M impact | EQUITY | Nov 05, 2026, 12:32 PM UTC
Middleby Expects Fiscal Q4 Revenue of $621M–$635M
Middleby expects fiscal fourth-quarter revenue of $621 million to $635 million, versus a FactSet estimate of $631 million.
M impact | EQUITY | Nov 05, 2026, 12:32 PM UTC
Astec Industries Reports Q3 Revenue of $352.4M
Astec Industries reported Q3 revenue of $352.4 million, versus a FactSet estimate of $375.5 million.
M impact | EQUITY | Nov 05, 2026, 12:32 PM UTC